academic article

• Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial..  JAMA.  320:1649-1658. 2018
• Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity..  Scientific reports.  7:-. 2017
• Neonatal outcomes of moderately preterm infants compared to extremely preterm infants..  Pediatric research.  82:297-304. 2017
• Effect of Depth and Duration of Cooling on Death or Disability at Age 18 Months Among Neonates With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial..  JAMA.  318:57-67. 2017
• Growth Outcomes of Preterm Infants Exposed to Different Oxygen Saturation Target Ranges from Birth. 2016
• Safety and Pharmacokinetics of Multiple Dose myo-Inositol in Preterm..  Pediatric research.  :-. 2016
• Early blood pressure, antihypotensive therapy and outcomes at 18-22 months' corrected age in extremely preterm infants..  Archives of disease in childhood. Fetal and neonatal edition.  :-. 2015
• Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012..  JAMA.  314:1039-1051. 2015
• Causes and timing of death in extremely premature infants from 2000 through 2011..  The New England journal of medicine.  372:331-340. 2015
• Neuroimaging and neurodevelopmental outcome in extremely preterm infants. 2015
• Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial..  JAMA : the journal of the American Medical Association.  312:2629-2639. 2014
• Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). 2014
• Neurodevelopmental outcomes of extremely low-gestational-age neonates with low-grade periventricular-intraventricular hemorrhage..  JAMA pediatrics.  167:451-459. 2013
• Outcomes of small for gestational age infants born at <27 weeks' gestation..  Pediatrics.  163:55-60.e1-3. 2013
• Pharmacokinetics and safety of a single intravenous dose of myo-inositol in preterm infants of 23-29 wk..  Pediatric research.  74:721-729. 2013
• Ten-year review of major birth defects in VLBW infants..  Pediatrics.  132:49-61. 2013
• Feasibility study of early blood pressure management in extremely preterm infants..  The Journal of pediatrics.  161:65-9.e1. 2012
• Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants.  Pediatrics.  129:e914-e922. 2012
• Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial.  E Engl J Med.  367:2495-2504. 2012
• Risk factors for post-neonatal intensive care unit discharge mortality among extremely low birth weight infants. 2012
• Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants..  American journal of respiratory and critical care medicine.  183:1715-1722. 2011
• Early CPAP versus surfactant in extremely preterm infants..  The New England journal of medicine.  362:1970-1979. 2010
• Survival and morbidity outcomes for very low birth weight infants with Down syndrome..  Pediatrics.  126:1132-1140. 2010
• Target ranges of oxygen saturation in extremely preterm infants..  The New England journal of medicine.  362:1959-1969. 2010